Executive Steering Committee
The BioMaP-Consortium Executive Steering Committee (ESC) is made up of member-elected Chairs who serve in a volunteer capacity. The Chairs advise the BioMaP-Consortium and represent the biopharmaceutical industry in peer-level engagements with the Consortium and its U.S. government partners.
ESC Chairs are not employed by the Consortium Management Firm (CMF) and do not have access to any member’s proprietary data held by the BioMaP-Consortium or the CMF. They are not provided advance knowledge of potential government solicitations and do not participate in, influence, or receive advance insight into source-selection or government funding decisions.
John Clapham
Supply Chain and Resiliency
John Clapham is CEO of PSC Biotech Corporation, PSC Software, BioTechnique, and Future Cures. He is the Founder of PSC Biotech Corporation and has been with the Company since founding the Company in 1996. John is a graduate of the University of Rhode Island, with a bachelor’s degree in chemical engineering in 1989. He has done graduate studies at the University of New Haven. He has worked for the United...
Flavia D'Souza
Industry Landscape, Gap Analysis, and Strategic BARDA Alignment
Flavia D’Souza is Co-Founder and Head of Quality at Sentio BioSciences, an FDA-registered pharmaceutical development and cGMP manufacturing small business. With more than 12 years of leadership in Quality and Regulatory Affairs & Business Development. She has guided two drug products from development through FDA approval and into commercial manufacturing and has additional new and generic drug products in the pipeline. As Chair of Industry Landscape, Gap Analysis, and Strategic...
Mandy Gervasio
Regulatory, Quality, and Policy
Mandy Gervasio is the Head of Quality and Regulatory Compliance at the Medicines for All Institute (M4ALL), based at Virginia Commonwealth University. She leads quality and compliance for M4ALL as it works to lower the cost of essential medicines, secure their supply chains, and bring critical pharmaceutical production back to the United States, and is architecting the enterprise framework that will carry the institute from research into GMP manufacturing. Over...
Dennis Hall
Regulatory, Quality, and Policy
Dennis Hall is Vice President of Advanced Manufacturing Technologies at the United States Pharmacopeia (USP), where he is shaping the future of how medicines are made, tested, and supplied. He leads initiatives that apply advanced manufacturing and quality technologies to solve systemic challenges in drug production and supply chains to strengthen resilience, accelerate innovation, and rebuild U.S. manufacturing competitiveness. With more than two decades at USP, Dennis has driven transformation...
Stephen Richardson
Voice of Membership
Stephen Richardson is a trusted connector experienced in helping clients identify and engage the right partners to accelerate development and commercialization. As Head of Strategic Partnerships at EverGlade Consulting, he aligns client needs with high-value partnerships that strengthen project execution and support long-term growth, working across several funding pathways, including the DoW and HHS. His perspective is grounded in more than relationship-building alone. Before stepping into strategic partnerships, Mr. Richardson...
Whitney Tull
Member Value Beyond Funding Opportunities
Whitney Tull joined STERIS in April 2019 to lead Government Affairs for the Company. In this role, she coordinates external engagement with a broad set of stakeholders comprising of associations, government officials, policy makers, and Customers for STERIS. Additionally, Whitney serves on STERIS’s Senior Management Team (SMT) and sits on the Ohio Life Sciences Board of Directors. Prior to joining STERIS, she managed U.S. Government Affairs for 11 years at...